European Journal of Surgical Oncology
Volume 32, Issue 10 , Pages 1093-1096 , December 2006

Cox-2 expression on tissue microarray of breast cancer

  • K. Park

      Affiliations

    • Department of Pathology, Inje University, Sanggye Paik Hospital, 761-1, Sanggye-dong, Nowon-gu, Seoul 139-707, South Korea
  • ,
  • S. Han

      Affiliations

    • Department of Surgery, Inje University, Sanggye Paik Hospital, 761-1, Sanggye-dong, Nowon-gu, Seoul 139-707, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 950 1018; fax: +82 2 950 1955.
  • ,
  • E. Shin

      Affiliations

    • Department of Pathology, Inje University, Sanggye Paik Hospital, 761-1, Sanggye-dong, Nowon-gu, Seoul 139-707, South Korea
  • ,
  • H.-J. Kim

      Affiliations

    • Department of Pathology, Inje University, Sanggye Paik Hospital, 761-1, Sanggye-dong, Nowon-gu, Seoul 139-707, South Korea
  • ,
  • J.-Y. Kim

      Affiliations

    • Department of Pathology, Inje University, Sanggye Paik Hospital, 761-1, Sanggye-dong, Nowon-gu, Seoul 139-707, South Korea

,Accepted 10 May 2006.

References 

  1. Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer. 2001;84:1188–1192
  2. Soslow RA, Dannenberg AJ, Woemer BM, Khan KN, Masferrer J, Koki A. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000;89:2637–2645
  3. Sheng H, Shao J, Washington MK, DuBois N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem. 2001;276:18075–18081
  4. Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer. 2001;8:97–114
  5. Parrett ML, Harris RE, Joarder FS, Ross MS, Claussen KP, Robertson FM. Cyclooxygenase-2 in human breast cancer. Int J Oncol. 1997;10:503–507
  6. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 expression in human breast cancer. J Natl Cancer Inst. 1998;90:455–460
  7. Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 1999;140:27–35
  8. Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002;62:632–635
  9. Denkert C, Winzer KJ, Muller BM, et al. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer. 2003;97:2978–2987
  10. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–847
  11. Park K, Kim J, Lim S, Han S, Lee JY. Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. Mod Pathol. 2003;16:937–943
  12. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: experience from a large study with long term follow-up. Histopathology. 1991;19:403–410
  13. Wulfing P, Diallo R, Muller C, et al. Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. J Cancer Res Clin Oncol. 2003;129:375–382
  14. Kelly LM, Hill ADK, Kennedy S, et al. Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up. Eur J Surg Oncol. 2003;29:707–710
  15. Witton CJ, Hawe SJK, Cooke TG, Bartlett JMS. Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology. 2004;45:47–54
  16. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. Cyclooxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002;55:429–434
  17. Han S, Park K, Bae BN, et al. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue arrays of node negative breast cancer. J Surg Oncol. 2003;83:241–247
  18. Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 2002;62:1676–1681
  19. Shim V, Gauthier ML, Sudilovsky D, et al. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res. 2003;63:2347–2350

 This work was supported by the 2005 Inje University Research Grant.

PII: S0748-7983(06)00217-4

doi: 10.1016/j.ejso.2006.05.010

European Journal of Surgical Oncology
Volume 32, Issue 10 , Pages 1093-1096 , December 2006